Ka Zhang

Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

A metabolite-augmented FIB-4 machine learning panel achieves superior liver fibrosis staging in chronic liver disease.

A metabolite-augmented FIB-4 machine learning panel achieves superior liver fibrosis staging in chronic liver disease.

Journal: Cell reports. Medicine
Published: November 05, 2025

The aMAP score combined with plasma cfDNA methylation testing for risk stratification in hepatitis population: a case-control study.

The aMAP score combined with plasma cfDNA methylation testing for risk stratification in hepatitis population: a case-control study.

Journal: Scientific reports
Published: October 21, 2025

Integrated analysis of gut microbiota structure and metabolic function in patients with cirrhosis and refractory ascites.

Integrated analysis of gut microbiota structure and metabolic function in patients with cirrhosis and refractory ascites.

Journal: Biomedical reports
Published: May 22, 2025

Comparative study of 3D MR elastography and intravoxel incoherent motion for the evaluation of hepatocellular carcinoma grade.

Comparative study of 3D MR elastography and intravoxel incoherent motion for the evaluation of hepatocellular carcinoma grade.

Journal: Liver research (Beijing, China)
Published: May 07, 2024

Relationship Between Platelets and the Clinical Efficacy of Umbilical Cord Mesenchymal Stem Cells for HBV-Related Acute-on-Chronic Liver Failure and Liver Cirrhosis: A Preliminary Clinical Study.

Relationship Between Platelets and the Clinical Efficacy of Umbilical Cord Mesenchymal Stem Cells for HBV-Related Acute-on-Chronic Liver Failure and Liver Cirrhosis: A Preliminary Clinical Study.

Journal: Stem cells translational medicine
Published: December 07, 2022

Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg.

Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg.

Journal: Frontiers in immunology
Published: July 19, 2022

Correlation of effective hepatic blood flow with liver pathology in patients with hepatitis B virus.

Correlation of effective hepatic blood flow with liver pathology in patients with hepatitis B virus.

Journal: Liver research (Beijing, China)
Published: August 24, 2021

The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis.

The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis.

Journal: Stem cell research & therapy
Published: June 07, 2021

Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis.

Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis.

Journal: Stem cell research & therapy
Published: May 05, 2020

SPC25 may promote proliferation and metastasis of hepatocellular carcinoma via p53.

SPC25 may promote proliferation and metastasis of hepatocellular carcinoma via p53.

Journal: FEBS open bio
Published: January 29, 2020

HBV promotes the recruitment of IL-17 secreting T cells via chemokines CCL22 and CCL17.

HBV promotes the recruitment of IL-17 secreting T cells via chemokines CCL22 and CCL17.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 19, 2019

Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs.

Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs.

Journal: Scientific reports
Published: March 15, 2017
Showing 1-12 of 24

Last Updated: 09/26/2026